COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • December 4th, 2013 • Egalet Corp • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of November 26, 2013 by and between Egalet Corporation, a Delaware corporation (the “Corporation”) and Shionogi Limited, a company organized under the laws of England and Wales (“Shionogi”).
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS DENOTE SUCH OMISSIONS. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • December 4th, 2013 • Egalet Corp • Pharmaceutical preparations • New York
This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into on this 26th day of November, 2013 (the “Effective Date”), by and among Egalet Limited, a company organized under the laws of England and Wales with its principal place of business at 33 St. James’ Square, London SW1Y 4JS, United Kingdom (“Egalet”), Shionogi Limited, a company organized under the laws of England and Wales with its principal place of business at 33 Kingsway, London, WC2B 6UF, United Kingdom (“Shionogi”), and, solely for the purposes of Sections 2.7, 7.1, 7.2, 11.1, 11.3, 11.5 and 12, Egalet Corporation, a company organized under the laws of Delaware with its principal place of business at 101 Lindenwood Blvd., Suite 22, Malvern, PA (“Egalet US”). Egalet and Shionogi may each be referred to herein individually as a “Party” and collectively as the “Parties.”
